Mitsunobu Mohri

Title: Mitsunobu Mohri: Innovator in Pharmaceutical Compounds

Introduction

Mitsunobu Mohri is a notable inventor based in Mishima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues.

Latest Patents

Mitsunobu Mohri holds 3 patents that focus on benzothiazepine and benzothiepine compounds. His latest patents include a pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, as well as a pharmaceutical aimed at treating hepatic disorders associated with cholestasis, specifically primary biliary cirrhosis and primary sclerosing cholangitis. Additionally, he has developed a pharmaceutical that serves as a therapeutic agent for obesity, fatty liver, and steatohepatitis. These compounds are represented by specific formulas that include a thioamide bond and a quaternary ammonium substituent.

Career Highlights

Mitsunobu Mohri is currently associated with Asahi Kasei Pharma Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Mitsunobu Mohri has collaborated with notable coworkers, including Takehiko Sasahara and Ken-Ichi Kasahara. Their combined expertise has contributed to the success of their projects and innovations.

Conclusion

Mitsunobu Mohri's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to impact the development of therapeutic agents that address critical health challenges.